NCT00220766 - Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

March 31, 2004

Conditions

Immunologic Deficiency SyndromeAgammaglobulinemiaSevere Combined ImmunodeficiencyWiskott-Aldrich SyndromeCommon Variable Immunodeficiency

Interventions

DRUG

Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified

DRUG

Dextrose, 5% in Water

Trial Locations (13)

International Center for Interdisciplinary Studies of Immunology, Washington D.C.

Allergy Associates of the Palm Beaches, North Palm Beach

University of South Florida College of Medicine, St. Petersburg

Departments of Medicine and Microbiology, Birmingham

Optimed Research, LLC, Columbus

University Hospitals of Cleveland, Cleveland

Allergy, Asthma, and Immunology, Omaha

The Clinical Trials Center, Children's Hospital, New Orleans

National Jewish Medical and Researach Center, Denver

3031 Hospital Drive Northwest, Calgary

St. Paul's Hospital, Vancouver

Saint Michael's Hospital, Toronto

The Hospital for Sick Children, Toronto